Dr. Martens (DOCS) H1 2025 earnings summary

Executive summary

• First half results met expectations, with revenue and profit declines driven by weak USA boots market and lower wholesale demand, while strategic focus remained on USA DTC turnaround, cost reduction, product-led marketing, and balance sheet strengthening.

• Cost action plan implemented, targeting £25 million in annualized savings by FY26, mainly from headcount reductions, and inventory reduction initiatives executed ahead of schedule.

• Significant reductions in inventory (down £69.1 million year-over-year) and net debt (down £130 million year-over-year), with successful refinancing completed.

• Interim dividend of 0.85p declared, reduced by 46% and consistent with prior guidance.

• Marketing pivoted to product attributes and premium positioning, with new campaigns and product launches.

Financial highlights

• H1 FY25 revenue: £324.6 million (down 18% year-over-year, 16% at constant currency); DTC revenue: £183.0 million (down 6.8%); Wholesale: £141.6 million (down 29%).

• Adjusted EBIT: £(4.3) million (vs. £39.7 million profit in H1 FY24); Adjusted PBT: £(17.9) million (vs. £25.2 million profit); Reported PBT: £(28.7) million.

• Gross margin: 64.0% (down 0.4pts year-over-year); EBIT margin: -4.7% (down 14.9pts); Adjusted EPS: (1.3)p (vs. 1.9p); Basic EPS: (2.2)p.

• Exceptional costs of £9.2 million to £9.3 million, mainly related to cost action program and director joining costs.

• Net debt reduced by £130 million year-over-year; net debt/EBITDA at 2.0x–2.3x, well below covenants.

Outlook and guidance

• FY25 guidance unchanged: positive USA DTC growth expected in H2, while USA wholesale to decline double digits for FY25.

• Inventory reduction of ~£40 million planned, with net debt target £310 million–£330 million (including leases).

• New store openings revised to ~15 (from 25–30); capex guidance reduced to ~£30 million.

• Currency headwind for FY25 estimated at ~£18 million to revenue and ~£6 million to PBT; no price increases planned for like-for-like products in Autumn Winter 2025.